A comprehensive toxicity evaluation in rats after long-term oral Gelsemium elegans exposure - 19/03/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 13 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | G. elegans did not cause significant toxic reaction in the rats after long-term exposure. |
• | G. elegans can be potentially developed as a drug based on its pharmacological activity. |
• | G. elegans’s toxic reaction caused by an imbalance of the neurotransmitter γ-aminobutyric acid/glutamate transformation. |
Abstract |
Background |
Gelsemium elegans (G. elegans) is a flowering plant of the Loganiaceae family, which had been used in traditional Chinese herb medicine for many years for the treatment of rheumatoid pain, neuropathic pain, spasticity, skin ulcers, anxiety and cancer. Acute toxicity of the plant severely limits the application and development of G. elegans; however, long-term toxicity of exposure to G. elegans has not been illuminated.
Purpose |
This study is a comprehensive observation of the effects of long-term exposure (21 days at 70 mg/kg) to G. elegans in rats.
Methods and Results |
The histopathological examination showed only a mild glial cell proliferation in the brain, and no lesions were observed in other organs. No abnormal changes in the biochemical parameters were observed that would have significant effects. The identification and analysis of absorbed natural ingredients showed that the active ingredients of the G. elegans could distribute to various tissues, and six compounds were identified in the brain, suggesting that they could cross the blood-brain barrier. Based on the intestinal content metabolomics, the tryptophan (Trp) biosynthesis, bile acid synthesis and bile secretion pathways have attracted our attention. Plasma metabolomic results showed that uric acid (UA) was significantly increased. The results of the brain metabolomic tests showed that the level of pyridoxal (PL) was decreased; considering the expression levels of the related enzymes, it was hypothesized that the level of pyridoxal 5′-phosphate (PLP) was decreased. PLP was important for the regulation of the neuronal γ-aminobutyric acid (GABA)/glutamate (Glu) interconversion and therefore neuronal excitability. The data of the study suggested that toxic reaction caused by G. elegans was due to a disruption of the balance of the neurotransmitter GABA/Glu transformation.
Conclusions |
Overall, G. elegans did not cause significant toxic reaction in the rats after long-term exposure. The results were significant for the future clinical applications of G. elegans and suggested that G. elegans could be potentially developed as a drug. The study provided a scientific basis for investigation of the mechanisms of toxicity and detoxification.
Le texte complet de cet article est disponible en PDF.Abbreviations : BCA, CE, CUR, DP, EIC, ESI, FA, FC, GABA, GAD, GDP, G. elegans, Glu, HPLC/QqTOF-MS, IDA, ISVF, KP, Kyn, LC–MS, MRM, NH4AC, NH4F, NH4OH, OPLS-DA, P, PBS, PCA, PDXK, PDXP, PL, PLP, PLS-DA, PN, PNP, PNPO, PM, PMP, QC, RT, SDS-PAGE, SPF, Trp, UA, UHPLC, VB6, VIP, WB
Keywords : Gelsemium elegans, Metabolomics, Vitamin B6, γ-aminobutyric acid, Glutamate
Plan
Vol 137
Article 111284- mai 2021 Retour au numéro
Article précédent
- RNA-Seq analysis of the protection by Dendrobium nobile alkaloids against carbon tetrachloride hepatotoxicity in mice
- Ya Zhang, Jinxin Zhou, Jiajia Liu, Shujun Li, Shaoyu Zhou, Chengchen Zhang, Yan Wang, Jingshan Shi, Jie Liu, Qin Wu
- Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia
- Danlan Fu, Junfei Huang, Kaitao Li, Yuxin Chen, Ye He, Yang Sun, Yilong Guo, Lijuan Du, Qian Qu, Yong Miao, Zhiqi Hu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?